Tests for Type 2 Diabetes

  1. ๐Ÿ“š Citations
  2. ๐Ÿฆ  Taxons (Bacteria) report by studies
  3. ๐Ÿฅฃ Candidates for improving (avoids and takes)
  4. ๐Ÿ”ฎ Bacteria Related Conditions
  5. es-xenogene is located in Spain and is expensive compared to others

Some 16s providers support download of FASTQ (raw data - BIG FILES). These can be processed thru other services (at the moment, Thryve and Biomesight offers free processing). The bacteria is determine by computer algorithms, which differs from lab to lab.

  1. Biomesight and BiomeSightRdp ships worldwide - including the US
  2. Thryve is now Ombre Labs but only ships to the US
  3. CosmosId is available thru NirvanaBiome
  4. Medivere is based in Germany
  5. American Gut
  6. Xenogene is both the most expensive and most detail for rare bacteria. They are based in Spain
  7. uBiome is no longer in business
The Percentage of significant bacteria each test reports on
Name Percentage
FASTQ processed thru both Thryve and BiomeSight 94.6%
Thryve 91.5%
uBiome 89.9%
es-xenogene 89.1%
Thorne 88.4%
BiomeSight 86.8%
CerbaLab 85.3%
SequentiaBiotech 85.3%
CosmosId 84.5%
BiomeSightRdp 84.5%
Medivere 79.8%
bugspeak 72.1%
AmericanGut 67.4%
Microba 63.6%
Tiny 62%
Gut Zoomer (vibrant-wellness) 51.2%
GanzimmunDiag 47.3%
Laboratorio Teletest 43.4%
Microba1 39.5%
DayTwo 27.9%
Metagenomics Stool (De Meirleir) (16s Limited) 27.1%
Genova Gi Effects (cfu/g) 26.4%
Diagnostic Solution GI-Map (cfu/gm) 24%
GanzImmun Diagnostic A6 (cfu/gm) 22.5%
Microbiome Healthpath Maxi 20.9%
Medivere Mikrobiom Plus Stuhlanalyse 20.2%
GI360 Stool (UK) 18.6%
Biovis Microbiome Plus (cfu/g) 18.6%
Tarmkollen Mega 17.1%
Nordic Laboratories 14.7%
Viome (Latest Reports Fail to provide ANY measurements) 14%
NutriPATH 11.6%
Bioscreen (cfu/gm) 10.9%
GI EcologiX (Invivo) 10.1%
Smart Gut (ubiome 16s - Limited Taxonomy) 10.1%
Medivere: Darm Mikrobiom Stuhltest (16s limited) 9.3%
GanzImmun Diagnostics AG Befundbericht 9.3%
InVitaLab (cfu/gm) 7%
Kyber Kompakt (cfu/g) 6.2%
Medivere: Gesundsheitscheck Darm (16s Limited) 6.2%
Verisana (cfu/ml) aka (kbe/ml) 5.4%
Medivere: Darn Magen Diagnostik (16s Limited) 5.4%
Genova Parasitology (cfu/g) 3.9%

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 ยงโ€ฏ1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)